MENU
+Compare
RYTM
Stock ticker: NASDAQ
AS OF
Sep 3, 04:59 PM (EDT)
Price
$101.83
Change
-$2.38 (-2.28%)
Capitalization
6.92B

RYTM Rhythm Pharmaceuticals Forecast, Technical & Fundamental Analysis

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company... Show more

Industry: #Biotechnology
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RYTM with price predictions
Sep 02, 2025

Momentum Indicator for RYTM turns positive, indicating new upward trend

RYTM saw its Momentum Indicator move above the 0 level on August 04, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RYTM advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 218 cases where RYTM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RYTM moved out of overbought territory on August 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for RYTM turned negative on August 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

RYTM broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RYTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYTM's P/B Ratio (312.500) is very high in comparison to the industry average of (19.852). P/E Ratio (0.000) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (41.667) is also within normal values, averaging (322.082).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RYTM is expected to report earnings to fall 8.35% to -68 cents per share on November 11

Rhythm Pharmaceuticals RYTM Stock Earnings Reports
Q3'25
Est.
$-0.69
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.07
The last earnings report on August 05 showed earnings per share of -75 cents, missing the estimate of -67 cents. With 214.12K shares outstanding, the current market capitalization sits at 6.92B.
A.I. Advisor
published General Information

General Information

a developer of peptide therapeutics for metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
222 Berkeley Street
Phone
+1 857 264-4280
Employees
226
Web
http://www.rhythmtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KSOAX156.610.34
+0.22%
Kinetics Small Cap Opportunities Adv A
NZDCNY4.21N/A
N/A
New Zealand Dollar - China Yuan
FGSIX69.17-0.41
-0.59%
Federated Hermes MDT Mid Cap Growth IS
AWAAX23.72-0.15
-0.63%
AB Wealth Appreciation Strategy A
MECEX14.68-0.13
-0.88%
NYLI Epoch Capital Growth Class C

RYTM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with VRNA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then VRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
+1.03%
VRNA - RYTM
46%
Loosely correlated
+0.18%
CRNX - RYTM
44%
Loosely correlated
+7.45%
RVMD - RYTM
42%
Loosely correlated
+4.11%
OCUL - RYTM
41%
Loosely correlated
+4.01%
IDYA - RYTM
40%
Loosely correlated
+3.79%
More